Additionally, NSUN2 collaborates with YBX1 to stabilize HDGF3 mRNA by recruiting ELAVL1 and targeting the m5C modification site in the HDGF 3′untranslated region, ultimately promoting bladder cancer progression. Here, YBX1 is linked to urinary bladder carcinoma.